On November 4 – 6, 2014 the FDA’s Office of Medical Policy and the Duke School of Medicine will co-sponsor the Sixth Annual Clinical Investigator’s course in College Park, MD.

This extensive 3-day course focuses on nonclinical, early clinical, and phase 3 studies; issues in the design and analysis of trials; safety and ethical considerations; and FDA’s regulatory requirements related to the performance and evaluation of clinical studies. (fda.gov)

During this event, CTTI will be represented in the Session 6 Roundtable titled The Clinical Investigator’s Role in Drug Development: a multi-stakeholder perspective at 2:15 pm on Thursday, November 6. To view the agenda for the entire program, click here.

We look forward to connecting with our colleagues at this event.